Farmed Trout Disease Management and Welfare

How disease prevention and management in trout aquaculture affects fish welfare and the limitations of current approaches.

Key Facts

Infectious pancreatic necrosis, bacterial kidney disease, and proliferative kidney disease are major trout welfare threats.
Disease outbreaks in high-density trout systems can kill up to 100% of affected cohorts.
Vaccination programs have reduced antibiotic use in Norwegian salmon and trout farming by over 99%.
Genetic selection for disease resistance improves welfare outcomes without requiring pharmaceutical intervention.
Mortality removal twice daily prevents secondary infection and reduces disease spread.
Reducing stocking density is the single most effective disease prevention measure for trout welfare.

Welfare Considerations

Disease in trout aquaculture causes welfare harms including anorexia, lethargy, hemorrhage, and chronic physiological stress in affected fish. The high stocking densities that maximize profitability simultaneously maximize disease transmission, creating a fundamental tension between economic and welfare goals. Prevention through vaccination, genetic resistance, and density management is both the most welfare-positive and ultimately the most economically rational approach. Treatment when disease occurs requires accurate diagnosis and appropriate pharmaceutical intervention, as delayed treatment prolongs suffering while increasing mortality. The welfare of individual trout during disease events depends on early detection, prompt intervention, and humane removal of moribund individuals.

What You Can Do

Choose farmed trout products from certified producers with documented disease prevention programs.
Support development of vaccines for trout diseases to reduce antibiotic dependence.
Advocate for stocking density regulations that prioritize fish welfare in trout aquaculture.
Support research into trout disease resistance breeding to reduce welfare harms from disease outbreaks.